相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Karrune V. Woan et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
The GP2 peptide: A HER2/neu-based breast cancer vaccine
Kevin S. Clive et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Utility of Characteristic QTOF MS/MS Fragmentation for MHC Class I Peptides
Hernando Escobar et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and S
Martin L. Biniossek et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Oral valproic acid for epilepsy -: long-term experience in therapy and side effects
Thorsten Gerstner et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models
Edward F. Rosloniec et al.
JOURNAL OF AUTOIMMUNITY (2006)
Personalized peptide vaccines: A new therapeutic modality for cancer
Kyogo Itoh et al.
CANCER SCIENCE (2006)
The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules
C Watts
NATURE IMMUNOLOGY (2004)
Absence of γ-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes
MA Haque et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation
CS Hsieh et al.
JOURNAL OF IMMUNOLOGY (2002)
Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation
A Osborne et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors
WJ Magner et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
